Ashley P. Hancock

465 total citations
10 papers, 306 citations indexed

About

Ashley P. Hancock is a scholar working on Immunology and Allergy, Oncology and Clinical Biochemistry. According to data from OpenAlex, Ashley P. Hancock has authored 10 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology and Allergy, 3 papers in Oncology and 3 papers in Clinical Biochemistry. Recurrent topics in Ashley P. Hancock's work include Paraoxonase enzyme and polymorphisms (3 papers), Allergic Rhinitis and Sensitization (3 papers) and Asthma and respiratory diseases (3 papers). Ashley P. Hancock is often cited by papers focused on Paraoxonase enzyme and polymorphisms (3 papers), Allergic Rhinitis and Sensitization (3 papers) and Asthma and respiratory diseases (3 papers). Ashley P. Hancock collaborates with scholars based in United Kingdom and Ireland. Ashley P. Hancock's co-authors include Panayiotis A. Procopiou, Keith Biggadike, Yemisi Solanke, Wendy R. Irving, Michael Snowden, Richard Angell, Onkar Singh, Christos V. Ioannou, A.J. Harker and Helen E. Weston and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of the Chemical Society Perkin Transactions 1.

In The Last Decade

Ashley P. Hancock

10 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley P. Hancock United Kingdom 7 84 79 77 59 51 10 306
Yemisi Solanke United Kingdom 10 159 1.9× 184 2.3× 77 1.0× 60 1.0× 36 0.7× 16 472
Ze'ev Shaked United States 5 75 0.9× 269 3.4× 5 0.1× 12 0.2× 24 0.5× 7 381
Kyung-Hoon Lee United States 10 37 0.4× 355 4.5× 14 0.2× 17 0.3× 159 3.1× 10 619
K. G. Scrimgeour United States 16 60 0.7× 331 4.2× 4 0.1× 162 2.7× 34 0.7× 31 563
Nikolay V. Lukashev Russia 15 331 3.9× 216 2.7× 5 0.1× 63 1.1× 21 0.4× 40 583
Emmanuelle Mothes France 9 181 2.2× 138 1.7× 14 0.2× 2 0.0× 114 2.2× 11 439
Fathima Shazna Thowfeik United States 6 43 0.5× 132 1.7× 8 0.1× 3 0.1× 23 0.5× 7 286
Camelia Baleanu‐Gogonea United States 7 16 0.2× 265 3.4× 10 0.1× 30 0.5× 69 1.4× 13 443

Countries citing papers authored by Ashley P. Hancock

Since Specialization
Citations

This map shows the geographic impact of Ashley P. Hancock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley P. Hancock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley P. Hancock more than expected).

Fields of papers citing papers by Ashley P. Hancock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley P. Hancock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley P. Hancock. The network helps show where Ashley P. Hancock may publish in the future.

Co-authorship network of co-authors of Ashley P. Hancock

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley P. Hancock. A scholar is included among the top collaborators of Ashley P. Hancock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley P. Hancock. Ashley P. Hancock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Procopiou, Panayiotis A., John W. Barrett, Richard J. D. Hatley, et al.. (2024). Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors. Journal of Medicinal Chemistry. 67(19). 17497–17519. 1 indexed citations
2.
3.
Procopiou, Panayiotis A., Alison J. Ford, Ashley P. Hancock, et al.. (2017). Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 27(21). 4914–4919. 2 indexed citations
4.
Procopiou, Panayiotis A., Ashley P. Hancock, Simon T. Hodgson, et al.. (2016). The discovery of quinoline based single-ligand human H1 and H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(24). 5855–5859. 6 indexed citations
5.
Procopiou, Panayiotis A., Christopher R. Browning, Kenneth L. Clark, et al.. (2011). The Discovery of Phthalazinone-Based Human H1and H3Single-Ligand Antagonists Suitable for Intranasal Administration for the Treatment of Allergic Rhinitis. Journal of Medicinal Chemistry. 54(7). 2183–2195. 28 indexed citations
6.
Angell, Richard, Keith Biggadike, Stephen S. Flack, et al.. (2002). Novel glucocorticoid antedrugs possessing a 21-(γ-lactone) ring. Journal of the Chemical Society Perkin Transactions 1. 831–839. 4 indexed citations
7.
Giblin, Gerard M.P., Ian B. Campbell, Ashley P. Hancock, et al.. (2001). 6,6′-Bis(2-hydroxyphenyl)-2,2′-bipyridine manganese(III) complexes: A novel series of superoxide dismutase and catalase mimetics. Bioorganic & Medicinal Chemistry Letters. 11(11). 1367–1370. 26 indexed citations
8.
Procopiou, Panayiotis A., Keith Biggadike, Ashley P. Hancock, et al.. (2001). Novel Glucocorticoid Antedrugs Possessing a 17β-(γ-Lactone) Ring. Journal of Medicinal Chemistry. 44(4). 602–612. 38 indexed citations
9.
Biggadike, Keith, Richard Angell, Ashley P. Hancock, et al.. (1999). Selective Plasma Hydrolysis of Glucocorticoid γ-Lactones and Cyclic Carbonates by the Enzyme Paraoxonase: An Ideal Plasma Inactivation Mechanism. Journal of Medicinal Chemistry. 43(1). 19–21. 157 indexed citations
10.
Giblin, Gerard M.P., et al.. (1993). Semi-synthetic qualestatins: Squalene synthase inhibition and antifungal activity. The SAR of C6 and C7 modifications. Bioorganic & Medicinal Chemistry Letters. 3(12). 2605–2610. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yemisi Solanke Breakdown of academic impact, for papers by Ze'ev Shaked Breakdown of academic impact, for papers by Kyung-Hoon Lee Breakdown of academic impact, for papers by K. G. Scrimgeour Breakdown of academic impact, for papers by Nikolay V. Lukashev Breakdown of academic impact, for papers by Emmanuelle Mothes Breakdown of academic impact, for papers by Fathima Shazna Thowfeik Breakdown of academic impact, for papers by Camelia Baleanu‐Gogonea
Rankless by CCL
2026